Share this article and save a life!
$110 million just went into fixing Medicare. Here is why that matters.
Pearl Health raised $50 million in Series C equity and locked in a $60 million credit facility, according to Startup Geek citing Axios Pro Rata.
The lead investor is Andreessen Horowitz. Viking Global Investors, AlleyCorp, and Ulysses Capital also participated.
This is not just another health tech raise. This is a bet on a specific, hard problem.
Pearl Health builds the operating system for value-based care in Medicare. Their platform synthesizes claims data, ADT feeds, and EHR data to identify which patients need attention before costs spiral, guide care teams on next steps, and automate the administrative work that burns out clinicians.
Here is what they have built so far, according to their own site:
• 10,000 providers across 40+ states
• 250,000 Medicare beneficiaries on the platform
• $3.6 billion in healthcare premiums managed
• 2x growth in lives covered year-over-year
• 1-3% medical loss ratio improvement in year one
• 25% potential workload reduction for care teams
That last number is the one I keep coming back to.
Clinician burnout is not a morale problem. It is an access problem. If AI can take a quarter of the administrative burden off providers, more patients get seen, quality scores go up, and the total cost of care goes down. That is the whole value-based care thesis playing out in real time.
A16z does not write checks this size into a crowded space without a thesis. Their thesis here is clear: Medicare is moving toward value-based models at scale, providers need purpose-built infrastructure to compete in that world, and Pearl is building exactly that.
The credit facility alongside the equity round is also worth noting. It signals Pearl is not just burning capital to grow headcount. They are structuring capital to fund program expansion and potentially shared savings arrangements. That is a mature financing strategy for a company at this stage.
The Pearl Health Investment Signal Checklist
When evaluating healthcare AI deals in the value-based care space, I look for these signals:
• Real provider adoption, not just pilots (10,000 providers qualifies)
• Managed premium volume that proves financial accountability (here: $3.6B)
• Multi-year growth trajectory, not a single spike (here: 2x lives year-over-year)
• Lead investor with healthcare operator network (a16z Bio fits)
• Structured capital alongside equity (credit facility signals operational maturity)
• A measurable outcome tied to revenue (here: MLR improvement, workload reduction)
All six boxes checked. That is rare.
Worth saving if you are evaluating value-based care AI vendors or building a Medicare-focused strategy this year.
👉 Follow Jonathan Govette, CEO of Oatmeal Health, for daily healthcare insights on LinkedIn. Deeper dives in The Oatmeal Bite on Substack: https://news.oatmealhealth.com
Share this article and save a life!
Author:
CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/
